Gencirq Inc
GenCirq Inc, based in San Diego, CA, is at the forefront of designing a new generation of bacteria for cancer therapy. Leveraging the latest advances in synthetic biology, their novel bacterial platform enables the production and targeted delivery of therapeutics to disease sites within the human body.
Specializing in engineering bacteria for the treatment of disease, GenCirq's approach involves programming probiotic or clinically-relevant bacteria with tumor-homing capabilities to deliver a wide range of therapeutics to solid tumors. Their innovative Synchronized Lysis Circuit ensures local delivery of therapeutics, enhancing the safety and efficacy of cancer therapies.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
